Rocket Lab Gets Fresh Buy Rating With 29% Upside After 95th Launch

Rocket Lab just hit a milestone that's hard to ignore, and Wall Street is taking notice.

The space launch company completed its 95th Electron rocket mission on September 11, a flight nicknamed "Happily Ever Faster" that deployed an Earth-observation satellite into low orbit for a confidential customer. It was the company's 16th successful mission of 2026, and shares climbed roughly 1.5% in premarket trading on the news, building on a 1.13% gain the prior session.

The launch success landed the same day Raymond James initiated coverage of Rocket Lab with an Outperform rating and an $80 price target, implying about 29% upside from current levels near $62. Analyst Brian Gesuale pointed to strong sales momentum and backlog growth as the key drivers behind the call, according to reporting from TipRanks that broke down the new coverage.

Raymond James isn't alone in the bullish camp. Berenberg Bank analyst Michael Filatov also carries a Buy rating on the stock, with an even higher $83 price target, according to a CoinCentral report corroborating the coverage initiation. Filatov's thesis centers on Electron's steady cadence plus the upcoming Neutron rocket as the next leg of growth, and he specifically called out limited launch capacity as an emerging bottleneck across the entire space sector — a dynamic that favors incumbents like Rocket Lab with proven hardware already flying.

Wall Street overall carries a Strong Buy consensus on RKLB, with 14 Buy ratings and 3 Holds over the past three months, and an average price target of $110.13 — suggesting 78% upside from current levels.

That gap between the stock price and where analysts see it heading is the story here. Rocket Lab shares are actually down about 11% year-to-date despite the steady launch cadence and expanding institutional interest — BlackRock took a new position in the second quarter worth more than $4.1 billion, and institutional investors now hold nearly 72% of the company, per the CoinCentral report. RFG Advisory also added roughly $1.95 million in shares during the same quarter.

There's a real counterpoint worth weighing before chasing the upside case. Filatov himself flagged execution risk and noted the stock already trades at a rich valuation relative to current fundamentals — he views pullbacks as entry points rather than the stock being cheap outright today. Rocket Lab's Q2 revenue of $234 million beat estimates, but the company posted an $0.08 per-share loss, missing the smaller loss analysts had modeled. Insiders have also sold roughly $313 million in shares over the past 90 days, including sales from senior executives, though those transactions were executed under pre-arranged 10b5-1 trading plans rather than signaling a fresh negative view on the business.

The bigger swing factor for the stock is Neutron, Rocket Lab's larger next-generation rocket still in development. There's no confirmed launch date yet, and the next milestone investors are watching for is simply hardware delivery to the launch pad — a reminder that the bulk of the bullish price targets assume Neutron eventually reaches orbit on a reasonable timeline. Any meaningful delay there would likely cap upside in the near term regardless of how well Electron keeps performing on its existing cadence.

For investors, the setup right now is a company executing cleanly on its existing small-rocket business while carrying real optionality on a much larger vehicle that isn't proven yet. The stock's roughly $2.4 billion cash position and $2.36 billion backlog give it runway to keep developing Neutron without needing to raise capital under duress, which matters given how expensive rocket development typically gets before a maiden flight.

Bottom line: with two fresh analyst calls both pointing well above the current price and a track record of 95 successful launches backing the base business, Rocket Lab looks like a name worth watching closely into Neutron's next milestone — just size the position with the valuation risk in mind.